Price Alert: Shares of Kintara (KTRA) Trade 6.78% Higher at Midday June 22

Equities Staff  |

Kintara Therapeutics Inc (NASDAQ: KTRA) has risen $0.0161 (6.78%) and sits at $0.25, as of 12:00:38 est on June 22.

2,377,240 shares exchanged hands.

The Company rose 27.14% over the last 5 days and shares advanced 52.05% over the last 30 days.

Kintara anticipates its next earnings on 2022-09-27.

For technical charts, analysis, and more on Kintara visit the company profile.

About Kintara Therapeutics Inc

Kintara Therapeutics, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. Kintara Therapeutics serves customers worldwide.

To get more information on Kintara Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Kintara Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets



Market Movers

Sponsored Financial Content